MT-1013
- Generic Name
- MT-1013
Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis
Phase 2
Recruiting
- Conditions
- Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
- Interventions
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Shaanxi Micot Technology Limited Company
- Target Recruit Count
- 310
- Registration Number
- NCT06976177
- Locations
- 🇨🇳
First Affiliated Hospital College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
MT1013 Injection for the Treatment of Patients With Secondary Hyperparathyroidism (SHPT) Undergoing Maintenance Dialysis
Phase 2
Recruiting
- Conditions
- Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Shaanxi Micot Technology Limited Company
- Target Recruit Count
- 102
- Registration Number
- NCT06747247
- Locations
- 🇨🇳
First Affiliated Hospital College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
Phase 2
Recruiting
- Conditions
- Secondary Hyperparathyroidism (SHPT) in Subjects with Chronic Kidney Disease (CKD) on Hemodialysis
- Interventions
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Shaanxi Micot Technology Limited Company
- Target Recruit Count
- 112
- Registration Number
- NCT06690242
- Locations
- 🇨🇳
First Affiliated Hospital College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
MT1013 Clinical TRIAL In Healthy Subject
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Shaanxi Micot Technology Limited Company
- Target Recruit Count
- 40
- Registration Number
- NCT04783090
- Locations
- 🇺🇸
WCCT Global, Inc., Cypress, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath